US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US5888477A
(en)
*
|
1993-01-29 |
1999-03-30 |
Aradigm Corporation |
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
|
US5672581A
(en)
*
|
1993-01-29 |
1997-09-30 |
Aradigm Corporation |
Method of administration of insulin
|
US5915378A
(en)
*
|
1993-01-29 |
1999-06-29 |
Aradigm Corporation |
Creating an aerosolized formulation of insulin
|
US5743250A
(en)
|
1993-01-29 |
1998-04-28 |
Aradigm Corporation |
Insulin delivery enhanced by coached breathing
|
US6024090A
(en)
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5873358A
(en)
*
|
1993-01-29 |
1999-02-23 |
Aradigm Corporation |
Method of maintaining a diabetic patient's blood glucose level in a desired range
|
US5970973A
(en)
*
|
1993-01-29 |
1999-10-26 |
Aradigm Corporation |
Method of delivering insulin lispro
|
US5507277A
(en)
|
1993-01-29 |
1996-04-16 |
Aradigm Corporation |
Lockout device for controlled release of drug from patient-activateddispenser
|
US6131567A
(en)
*
|
1993-01-29 |
2000-10-17 |
Aradigm Corporation |
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
|
EP1607086A1
(de)
*
|
1993-01-29 |
2005-12-21 |
Aradigm Corporation |
Verfahren zur Verwendung monomeren Insulins als Mittel zur Verbesserung der Reproduzierbarkeit inhalierten Insulins
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
AU689217B2
(en)
*
|
1994-03-07 |
1998-03-26 |
Novartis Ag |
Methods and compositions for pulmonary delivery of insulin
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
KR100389080B1
(ko)
|
1994-12-22 |
2003-10-17 |
아스트라제네카 악티에볼라그 |
부갑상선호르몬(pth)을포함하는흡입용치료제제
|
CZ288146B6
(en)
|
1994-12-22 |
2001-05-16 |
Astra Ab |
Pharmaceutical aerosol preparation, process of its preparation and use
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US6852690B1
(en)
*
|
1995-08-22 |
2005-02-08 |
Amylin Pharmaceuticals, Inc. |
Method and composition for enhanced parenteral nutrition
|
US5724986A
(en)
*
|
1995-11-06 |
1998-03-10 |
Jones Medical Instrument Co. |
Casing and spirometer for metered dose inhaler
|
EP0812150A4
(de)
|
1995-12-28 |
1999-03-10 |
Cygnus Therapeutic Systems |
Kontinuierliche überwachung für physiologische probenbestandteile
|
US5875776A
(en)
*
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
ES2140998B1
(es)
*
|
1996-05-13 |
2000-10-16 |
Univ Sevilla |
Procedimiento de atomizacion de liquidos.
|
US6595202B2
(en)
|
1996-05-13 |
2003-07-22 |
Universidad De Sevilla |
Device and method for creating aerosols for drug delivery
|
US6189803B1
(en)
|
1996-05-13 |
2001-02-20 |
University Of Seville |
Fuel injection nozzle and method of use
|
US6405936B1
(en)
|
1996-05-13 |
2002-06-18 |
Universidad De Sevilla |
Stabilized capillary microjet and devices and methods for producing same
|
US6187214B1
(en)
|
1996-05-13 |
2001-02-13 |
Universidad De Seville |
Method and device for production of components for microfabrication
|
US6792940B2
(en)
|
1996-05-13 |
2004-09-21 |
Universidad De Sevilla |
Device and method for creating aerosols for drug delivery
|
US6386463B1
(en)
|
1996-05-13 |
2002-05-14 |
Universidad De Sevilla |
Fuel injection nozzle and method of use
|
US6299145B1
(en)
|
1996-05-13 |
2001-10-09 |
Universidad De Sevilla |
Device and method for fluid aeration via gas forced through a liquid within an orifice of a pressure chamber
|
US6196525B1
(en)
|
1996-05-13 |
2001-03-06 |
Universidad De Sevilla |
Device and method for fluid aeration via gas forced through a liquid within an orifice of a pressure chamber
|
US6116516A
(en)
|
1996-05-13 |
2000-09-12 |
Universidad De Sevilla |
Stabilized capillary microjet and devices and methods for producing same
|
US5954685A
(en)
*
|
1996-05-24 |
1999-09-21 |
Cygnus, Inc. |
Electrochemical sensor with dual purpose electrode
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5922288A
(en)
*
|
1997-05-29 |
1999-07-13 |
Herst; C. V. Taylor |
Device for isolating a component of a physiological sample
|
US5965535A
(en)
|
1997-09-12 |
1999-10-12 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
EP1037713B1
(de)
|
1997-12-17 |
2002-07-10 |
Universidad de Sevilla |
Verfahren zur erzeugung von hohlen tröpfchen
|
US20080219976A1
(en)
*
|
1997-12-19 |
2008-09-11 |
Naomi Balaban |
Methods and compositions for treatment and prevention of staphylococcal infections
|
US7323179B2
(en)
*
|
1997-12-19 |
2008-01-29 |
Naomi Balaban |
Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
|
US8287483B2
(en)
*
|
1998-01-08 |
2012-10-16 |
Echo Therapeutics, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US7066884B2
(en)
*
|
1998-01-08 |
2006-06-27 |
Sontra Medical, Inc. |
System, method, and device for non-invasive body fluid sampling and analysis
|
KR100620338B1
(ko)
|
1998-03-16 |
2006-09-13 |
넥타르 테라퓨틱스 |
에어로졸형 활성 제제 전달 방법
|
US6554798B1
(en)
|
1998-08-18 |
2003-04-29 |
Medtronic Minimed, Inc. |
External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
|
EP1862549A3
(de)
|
1998-09-15 |
2008-02-13 |
Naomi Balaban |
Target eines RNAIII-aktivierenden Proteins (TRAP)
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6450189B1
(en)
|
1998-11-13 |
2002-09-17 |
Universidad De Sevilla |
Method and device for production of components for microfabrication
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US20040171980A1
(en)
|
1998-12-18 |
2004-09-02 |
Sontra Medical, Inc. |
Method and apparatus for enhancement of transdermal transport
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
US20020054914A1
(en)
*
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
US20040258763A1
(en)
*
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
ES2228467T3
(es)
|
1999-02-03 |
2005-04-16 |
Biosante Pharmaceuticals, Inc. |
Particulas terapeuticas de fosfato calcico y metodos de fabricacion y su uso.
|
SE516826C2
(sv)
*
|
1999-06-18 |
2002-03-05 |
Shl Medical Ab |
Anordning i en inhalator med organ för aktivering och avaktivering av en kanister som svar på ett luftflöde
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ES2526707T3
(es)
*
|
1999-06-29 |
2015-01-14 |
Mannkind Corporation |
Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US6535523B1
(en)
*
|
1999-09-30 |
2003-03-18 |
Qualcomm Incorporated |
System and method for persistence vector based rate assignment
|
US6596261B1
(en)
*
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
WO2001074247A2
(en)
|
2000-04-03 |
2001-10-11 |
Iep Pharmaceutical Devices Inc. |
Method for measuring changes in the airways of humans and other mammals
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6629524B1
(en)
|
2000-07-12 |
2003-10-07 |
Ponwell Enterprises Limited |
Inhaler
|
US20050201981A1
(en)
*
|
2004-03-10 |
2005-09-15 |
Chih-Ping Liu |
Method of optimizing treatment with interferon-tau
|
US7073499B1
(en)
|
2001-02-06 |
2006-07-11 |
Injet Digital Aerosols Limited |
Inhaler with airflow regulation
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US20030185892A1
(en)
*
|
2001-08-17 |
2003-10-02 |
Bell Steve J. D. |
Intraocular delivery compositions and methods
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US6684880B2
(en)
*
|
2001-12-04 |
2004-02-03 |
Hewlett-Packard Development Company, L.P. |
Applicator for dispensing bioactive compositions and methods for using the same
|
SI1494732T1
(sl)
|
2002-03-20 |
2008-08-31 |
Mannking Corp |
Inhalacijski aparat
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
WO2003088961A1
(en)
*
|
2002-04-19 |
2003-10-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
US20040101481A1
(en)
*
|
2002-11-26 |
2004-05-27 |
Alexza Molecular Delivery Corporation |
Acute treatment of headache with phenothiazine antipsychotics
|
WO2003105768A2
(en)
*
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
US7185651B2
(en)
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
US7056494B2
(en)
*
|
2002-09-03 |
2006-06-06 |
Kos Pharmaceuticals, Inc. |
Method of treating a systemic disease
|
WO2004037843A2
(en)
*
|
2002-10-25 |
2004-05-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
WO2004041340A2
(en)
*
|
2002-10-30 |
2004-05-21 |
Nektar Therapeutics |
Increased dosage metered dose inhaler
|
CA2507159A1
(en)
|
2002-11-26 |
2004-06-10 |
Alexza Molecular Delivery Corporation |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
CA2526478A1
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
CA2511746C
(en)
|
2003-11-06 |
2013-03-26 |
Lifescan, Inc. |
Drug delivery pen with event notification means
|
CN101027082A
(zh)
*
|
2004-01-12 |
2007-08-29 |
曼恩坎德公司 |
降低2型糖尿病患者血清胰岛素原水平的方法
|
US7380550B2
(en)
*
|
2004-01-30 |
2008-06-03 |
Hewlett-Packard Development Company, L.P. |
Systems and methods for particle detection
|
US7819115B2
(en)
*
|
2004-01-30 |
2010-10-26 |
Hewlett-Packard Development Company, L.P. |
Inhalers and methods of controlling airflow in inhalers
|
DE602005021756D1
(de)
*
|
2004-02-13 |
2010-07-22 |
Nod Pharmaceuticals Inc |
Partikel mit kern aus calciumphosphat-nanopartikeln, biomolekül und gallensäure, herstellungsverfahren und therapeutische verwendung
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US7161787B2
(en)
*
|
2004-05-04 |
2007-01-09 |
Millipore Corporation |
Low power solenoid driver circuit
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
EP2626368B1
(de)
|
2004-07-19 |
2016-12-21 |
Biocon Limited |
Insulinoligomerkonjugate, Formulierungen und Verwendungen davon
|
JP5078014B2
(ja)
|
2004-08-20 |
2012-11-21 |
マンカインド コーポレイション |
ジケトピペラジン合成の触媒反応
|
HUE025151T2
(en)
|
2004-08-23 |
2016-01-28 |
Mannkind Corp |
Diceto-piperazine salts for drug delivery
|
US20060094944A1
(en)
|
2004-10-28 |
2006-05-04 |
Sontra Medical Corporation |
System and method for analyte sampling and analysis with error correction
|
WO2006050368A2
(en)
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
DK1901749T3
(en)
|
2005-05-18 |
2016-10-24 |
Raptor Pharmaceuticals Inc |
Aerosolized fluoroquinolones AND USES THEREOF
|
US8251904B2
(en)
|
2005-06-09 |
2012-08-28 |
Roche Diagnostics Operations, Inc. |
Device and method for insulin dosing
|
EP1919954B1
(de)
|
2005-08-30 |
2016-10-19 |
University of Miami |
Immunmodulierende tumornekrosefaktor-rezeptor-25 (tnfr25)-agonisten, antagonisten und immuntoxine
|
EP1928423B1
(de)
|
2005-09-14 |
2015-12-09 |
Mannkind Corporation |
Verfahren zur arzneimittelformulierung basierend auf der affinitätssteigerung von aktiven wirkstoffen für kristalline mikropartikel-flächen
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7432069B2
(en)
|
2005-12-05 |
2008-10-07 |
Sontra Medical Corporation |
Biocompatible chemically crosslinked hydrogels for glucose sensing
|
EP1986679B1
(de)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
Verfahren zur verbesserung der pharmazeutischen eigenschaften von mikropartikeln mit diketopiperazin und einem wirkstoff
|
US8962643B2
(en)
|
2006-02-24 |
2015-02-24 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the JAK pathway
|
JP2009533471A
(ja)
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
EP2032169A2
(de)
*
|
2006-05-23 |
2009-03-11 |
Tufts University |
Verfahren und zusammensetzungen zur behandlung und prävention von staphylococcus aureus-infektionen durch intereferenz mit opuc-operon-interaktion mit trap
|
JP5241714B2
(ja)
|
2006-07-07 |
2013-07-17 |
プロテウス デジタル ヘルス, インコーポレイテッド |
スマートな非経口送達システム
|
EP2425820B1
(de)
|
2007-02-11 |
2015-04-08 |
MAP Pharmaceuticals Inc |
Verfahren zur therapeutischen Verabreichung von DHE zur schnellen Linderung von Migräne bei gleichzeitiger Minimierung von Nebenwirkungsprofilen
|
EP2124723A1
(de)
|
2007-03-07 |
2009-12-02 |
Echo Therapeutics, Inc. |
Überwachungssystem für transdermale marker und verfahren für den nachweis von markern
|
EP2121088B1
(de)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
|
SI2152358T1
(sl)
|
2007-04-27 |
2011-08-31 |
Echo Therapeutics Inc |
Naprava za prodiranje skozi koĺ˝o za analizno merjenje ali za transdermalni prenos zdravil
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
US9125979B2
(en)
|
2007-10-25 |
2015-09-08 |
Proteus Digital Health, Inc. |
Fluid transfer port information system
|
WO2009067463A1
(en)
|
2007-11-19 |
2009-05-28 |
Proteus Biomedical, Inc. |
Body-associated fluid transport structure evaluation devices
|
KR101558026B1
(ko)
|
2008-06-13 |
2015-10-06 |
맨카인드 코포레이션 |
건조 분말 흡입기 및 약물 투여 시스템
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA2728523C
(en)
|
2008-06-20 |
2020-03-10 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
NO2344129T3
(de)
|
2008-10-07 |
2018-07-21 |
|
|
PT2346509T
(pt)
|
2008-10-07 |
2020-08-05 |
Horizon Orphan Llc |
Inalação de levofloxacina para redução da inflamação pulmonar
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
MX2011007750A
(es)
|
2009-01-23 |
2011-09-29 |
Rigel Pharmaceuticals Inc |
Composiciones y metodos para inhibicion de la ruta jak.
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US8538707B2
(en)
|
2009-03-11 |
2013-09-17 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
EP2440184B1
(de)
|
2009-06-12 |
2023-04-05 |
MannKind Corporation |
Diketopiperazin-mikropartikel mit definierten spefiischen oberflächenbereichen
|
SI2473170T1
(sl)
|
2009-09-04 |
2019-10-30 |
Horizon Orphan Llc |
Uporaba aerosoliziranega levofloksacina za zdravljenje cistične fibroze
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
US20130269684A1
(en)
|
2012-04-16 |
2013-10-17 |
Dance Pharmaceuticals, Inc. |
Methods and systems for supplying aerosolization devices with liquid medicaments
|
US9180261B2
(en)
|
2010-01-12 |
2015-11-10 |
Dance Biopharm Inc. |
Preservative free insulin formulations and systems and methods for aerosolizing
|
US9545488B2
(en)
|
2010-01-12 |
2017-01-17 |
Dance Biopharm Inc. |
Preservative-free single dose inhaler systems
|
WO2011092690A1
(en)
|
2010-01-26 |
2011-08-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
CN102905612A
(zh)
|
2010-02-01 |
2013-01-30 |
普罗秋斯数字健康公司 |
双腕式数据采集系统
|
JP5841951B2
(ja)
|
2010-02-01 |
2016-01-13 |
プロテウス デジタル ヘルス, インコーポレイテッド |
データ収集システム
|
CA2801936C
(en)
|
2010-06-21 |
2021-06-01 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
AU2012212269B2
(en)
|
2011-01-31 |
2016-05-19 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
KR101940832B1
(ko)
|
2011-04-01 |
2019-01-21 |
맨카인드 코포레이션 |
의약 카트리지용 블리스터 패키지
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2776053A1
(de)
|
2011-10-24 |
2014-09-17 |
MannKind Corporation |
Verfahren und zusammensetzungen zur schmerzbehandlung
|
JP6231548B2
(ja)
|
2012-03-23 |
2017-11-15 |
マテオン セラピューティクス, インコーポレイテッド |
カテプシンの阻害のための組成物および方法
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
EP2911690A1
(de)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
|
US10046123B2
(en)
|
2012-10-31 |
2018-08-14 |
Inhaletech Llc |
Systems and methods for administering pulmonary medications
|
WO2014144895A1
(en)
|
2013-03-15 |
2014-09-18 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
CA3172586A1
(en)
|
2013-07-31 |
2015-02-05 |
Avalyn Pharma Inc. |
Aerosol imatininb compounds and uses thereof
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
NZ722927A
(en)
|
2014-01-10 |
2022-07-29 |
Avalyn Pharma Inc |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10213564B2
(en)
*
|
2014-05-19 |
2019-02-26 |
Frank J. Cain |
Biomedical aural delivery systems and methods
|
US10610651B2
(en)
|
2014-06-09 |
2020-04-07 |
Aerami Therapeutics, Inc. |
Self-puncturing liquid drug cartridges and associated dispenser
|
US11273271B2
(en)
|
2014-07-01 |
2022-03-15 |
Aerami Therapeutics, Inc. |
Aerosolization system with flow restrictor and feedback device
|
US10857313B2
(en)
*
|
2014-07-01 |
2020-12-08 |
Aerami Therapeutics, Inc. |
Liquid nebulization systems and methods
|
US10471222B2
(en)
|
2014-07-01 |
2019-11-12 |
Dance Biopharm Inc. |
Aerosolization system with flow restrictor and feedback device
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
JP2019516485A
(ja)
|
2016-05-19 |
2019-06-20 |
マンカインド コーポレイション |
吸入を検出および監視するための機器、システム、および方法
|
WO2020015609A1
(zh)
*
|
2018-07-17 |
2020-01-23 |
微邦科技股份有限公司 |
驱动雾化器的方法与电路系统
|
WO2020092845A1
(en)
|
2018-11-01 |
2020-05-07 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
MX2022001596A
(es)
|
2019-08-08 |
2022-03-11 |
Rigel Pharmaceuticals Inc |
Compuestos y metodos para tratar sindrome de liberacion de citocinas.
|
MX2022001890A
(es)
|
2019-08-14 |
2022-04-26 |
Rigel Pharmaceuticals Inc |
Metodo para bloquear o mejorar el sindrome de liberacion de citocinas.
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
WO2023183377A1
(en)
|
2022-03-23 |
2023-09-28 |
Rigel Pharmaceuticals, Inc. |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|
WO2023250076A1
(en)
*
|
2022-06-23 |
2023-12-28 |
Hygieia, Inc. |
Systems and methods for identifying medical conditions or treatment issues using optimized diabetes patient management data
|